A ketamine survey you oughta take

If you compound ketamine, the Reagan-Udall Foundation for the FDA would like to know about it. It’s conducting a survey to get a better understanding of the current landscape of ketamine compounding — something important to know, especially as we all know there’s likely some kind of regulation coming down the pike.

The project isn’t interested in any particular potential regulation — it just aims to create a clearer picture of ketamine compounding today. That includes information like how data are collected and reported and what kinds of enforcement actions are taking place. Basically, “any areas that may benefit from further clarification or support from regulators.”

Your responses will remain anonymous, but aggregated themes and findings from this survey will be shared with FDA and in a public report. (If you provide an email address, you can receive a copy of the report when it becomes available.)

Click here if you can participate in the survey, and please respond by Friday, October 10. (Any questions? You can email Joy Eckert at the foundation.)